Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries

  • Piperni, Elisa
  • Vallès Colomer, Mireia
  • Asnicar, Francesco
Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p < 1e-16) and disorders linked to altered gut ecology (p < 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p < 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis., We thank the participants of the PREDICT program. This work was supported by Zoe Ltd. and TwinsUK, which are funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network, and the Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. It was partially supported by the American Gastroenterological Association Research Foundation’s Research Scholars Award to L.H.N., the Crohn’s and Colitis Foundation Career Development Award to L.H.N., and NIH/NIDDK K23DK125838 to L.H.N. L.H.N. is the Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine. The study was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European Union’s Horizon 2020 program (ONCOBIOME-825410 project, MASTER- 818368 project, and IHMCSA-964590) to N.S., by the European Union’s Horizon Europe program (DOMINO-101060218), by the European Union NextGenerationEU (INEST) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S. and R35 CA253178 to A.T.C., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Lifelines Biobank initiative has been made possible by the Dutch Ministry of Health, Welfare, and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen; the University of Groningen; and the Northern Provinces of the Netherlands. The authors acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants. J.F. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-CoG (No.101001678), NWO-VICI grant VI.C.202.022, the AMMODO Science Award 2023 for Biomedical Sciences from Stichting Ammodo, and the Netherlands Organ-on-Chip Initiative, an NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture, and Science of The Netherlands. A.Z. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-StG (No. 715772), NWO-VIDI grant 016.178.056, and the NWO Gravitation grant Exposome-NL (024.004.017). A.T.C. is partially supported by an American Cancer Society Research Professor Award.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Shared household environment structures the gut microbiota in a large family cohort with central areolar choroidal dystrophy

  • García-Gutiérrez, Enriqueta
  • Ponsero, Alise J.
  • Delgado, Jesús
  • Crispie, Fiona
  • Cotter, Paul D.
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
Central areolar choroidal dystrophy (CACD) is a rare monogenic hereditary retinal dystrophy characterised by progressive retinal pigment epithelium and choriocapillaris atrophy, photoreceptor loss, oxidative stress, and chronic inflammation. Emerging evidence suggests that the gut microbiota can modulate systemic inflammatory responses and may influence ocular health through the gut-eye axis. However, the contribution of the gut microbiota to CACD remains unexplored. In this pilot study, we investigated the gut microbiota composition of members of a large Spanish family carrying the PRPH2 Arg195Leu mutation associated with CACD. Faecal samples from 33 mutation carriers and 24 non-carrier household members were analysed using whole-metagenome shotgun sequencing. Taxonomic composition and bacterial diversity were compared adjusting for sequencing depth, age, and sex, accounting for shared household environment through paired and mixed-effects analyses. The findings suggest that gut microbiota variation in this CACD cohort is primarily driven by shared environmental factors rather than disease status at this depth of sequencing. Our study highlights the critical importance of accounting for household effects in microbiome studies of familial and rare genetic diseases and provides a robust framework for future investigations into the gut-eye axis using longitudinal or interventional designs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Unexplored microbial diversity from 2,500 food metagenomes and links with the human microbiome

  • Carlino, Niccolò
  • Blanco-Míguez, Aitor
  • Punčochář, Michal
  • Mengoni, Claudia
  • Pinto, Federica
  • Tatti, Alessia
  • Manghi, Paolo
  • Armanini, Federica
  • Avagliano, Michele
  • Barcenilla, Coral
  • Breselge, Samuel
  • Cabrera-Rubio, Raúl
  • Calvete-Torre, Inés
  • Coakley, Mairéad
  • Cobo-Díaz, José F.
  • De Filippis, Francesca
  • Dey, Hrituraj
  • Leech, John
  • Klaassens, Eline S
  • Knobloch, Stephen
  • O'Neil, Dominic
  • Quijada, Narciso M.
  • Sabater, Carlos
  • Skírnisdóttir, Sigurlaug
  • Valentino, Vincenzo
  • Walsh, Liam
  • Alvarez-Ordóñez, Avelino
  • Asnicar, Francesco
  • Fackelmann, Gloria
  • Heidrich, Vitor
  • Margolles Barros, Abelardo
  • Marteinsson, Viggó Thór
  • Rota Stabelli, Omar
  • Wagner, Martin
  • Ercolini, Danilo
  • Cotter, Paul D
  • Segata, Nicola
  • Pasolli, Edoardo
Complex microbiomes are part of the food we eat and influence our own microbiome, but their diversity remains largely unexplored. Here, we generated the open access curatedFoodMetagenomicData (cFMD) resource by integrating 1,950 newly sequenced and 583 public food metagenomes. We produced 10,899 metagenome-assembled genomes spanning 1,036 prokaryotic and 108 eukaryotic species-level genome bins (SGBs), including 320 previously undescribed taxa. Food SGBs displayed significant microbial diversity within and between food categories. Extension to >20,000 human metagenomes revealed that food SGBs accounted on average for 3% of the adult gut microbiome. Strain-level analysis highlighted potential instances of food-to-gut transmission and intestinal colonization (e.g., Lacticaseibacillus paracasei) as well as SGBs with divergent genomic structures in food and humans (e.g., Streptococcus gallolyticus and Limosilactobabillus mucosae). The cFMD expands our knowledge on food microbiomes, their role in shaping the human microbiome, and supports future uses of metagenomics for food quality, safety, and authentication., The MASTER EU Consortium was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement no 818368. The work was also partially supported by the European Union’s Horizon Europe programme (project DOMINO-101060218), the Italian Ministry of Foreign Affairs and International Cooperation (project FOODMICROHERITAGE-VN21GR09), the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG project microTOUCH-101045015) to N.S., the European Union’s Horizon 2020 programme (projects ONCOBIOME-825410 and IHMCSA-964590) to N.S., the MUR PNRR INEST-Interconnected Nord-Est Innovation Ecosystem by NextGenerationEU (project ECS00000043) to N.S., the National Cancer Institute of the National Institutes of Health (projects 1U01CA230551 and U01CA261961) to N.S., the Premio Internazionale Lombardia e Ricerca 2019 to N.S, the European Union’s Horizon 2020 programme (Marie Skłodowska-Curie project 101034371) to N.M.Q., the Spanish Ministry of Science and Innovation (Juan de la Cierva postdoctoral contract FJC2019-042125-I), the Science Foundation Ireland (SFI) under grant number SFI/12/RC/2273 (APC Microbiome Ireland), and SFI together with the Irish Department of Agriculture, Food, and the Marine, SFI/16/RC/3835 (VistaMilk) to P.D.C., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Draft genome sequences of two strains of Starmerella bacillaris of enological interest, FC54 and MUT5705

  • Di Gianvito, Paola
  • Morard, Miguel
  • Cristetti, Francesca
  • Cocolin, Luca
  • Rantsiou, Kalliopi
  • Querol, Amparo
  • Englezos, Vasileios
Starmerella bacillaris is a non-Saccharomyces yeast associated with enological niches. We present whole-genome sequences of strains FC54 and MUT5705, previously isolated from grapes and extensively characterized for their enological traits. Given the limited genomic resources, these data provide valuable insights into the genetic diversity and heterogeneity within this species., Part of this work was developed within the framework of the DOMINO project, which has received funding from the European Union’s Horizon Europe research and innovation program under grant agreement no. 101060218. MM and AQ acknowledge the award of the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

From "synthetic" to defined microbial communities for clearer terminology

  • Koch, Hanna
  • Clavel, Thomas
  • Mayr, Cintia
  • Coltman, Benjamin L.
  • Schloter, Michael
  • Vorholt, Julia A.
  • Sanz, Yolanda
  • Cernava, Tomislav
  • Beattie, Gwyn A.
  • Lange, Lene
  • Chaillou, Stéphane
  • Kovács, Ákos T.
  • Smidt, Hauke
  • Pieterse, Corné M. J.
  • Kostic, Tanja
  • Finkel, Omri M.
  • Lawson, Christopher E.
  • Cocolin, Luca
  • Mercado-Blanco, Jesús
  • Finn, Robert D.
  • Papadopoulou, Kalliope K.
  • Ryan, Matthew
  • Candela, Marco
  • Cotter, Paul D.
  • Berg, Gabriele
  • O'Sullivan, Orla
  • Delgado-Baquerizo, Manuel
  • Trivedi, Pankaj
  • Charles, Trevor C.
  • Singh, Brajesh K.
  • Brader, Günter
  • Marian, Malek
  • Sessitsch, Angela
4 páginas.- 1 figura.- 30 referencias, Consortia of microbial isolates, also known as synthetic communities (SynComs), are increasingly used to study and harness microbe-microbe and microbe-host interactions. Since “synthetic” potentially evokes negative connotations, we propose adopting the term “Defined Microbial Community” for practical applications., Thomas Clavel received funding from the German Research Foundation (DFG), project nos. 395357507—SFB1371, 403224013—SFB1382, 460129525—NFDI4Microbiota, and CL 481/17-1 - SPP2474. A.S., H.K., and B.L.C. acknowledge funding from the Austrian Science Fund (FWF; doi.org/10.55776/COE7). M.M., C.M., T.K., and A.S. received funding from European Union’s Horizon Europe programme under grant agreement no. 101131818 (Microbes-4-Climate), KKP from no. 101084163 (RATION). In addition, AS acknowledges funding from EU’s Horizon Europe programme under grant agreement no. 101083671 (MICROBIOMES4SOY) and FWF (MicroSuppress; DOI: 10.55776/P36288) and T.K. from EU’s Horizon Europe programme under grant agreement no. 101094353 (MICROBE). Á.T.K. acknowledges funding from EU’s Horizon Europe programme under grant agreement no. 101166968 (MicroClock, ERC Synergy), Y.S. from grant agreement no. 101084485 (TRIBIOME), and SC from grant agreement no. 101060218 (DOMINO). C.M.J.P. received funding from EU’s Horizon Europe programme no. 101060693 (BOLERO) and the Netherlands Organization for Scientific Research (NWO), project no. SPI.2022.003 and 024.004.014. M.D.-B. acknowledges support the project CPP2022_009702 (BIOCONSOIL), funded by MCIN/AEI/10.13039/501100011033 and by the EU-NextGenerationEU/PRTR. R.D.F. is supported by EMBL core funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development of autochthonous yeast starter cultures for Taggiasca table olives: Microbial ecology and metabolomic profile under standard and reduced-salt fermentation conditions

  • Vanzetti, Gaia
  • Traina, Chiara
  • Rantsiou, Kalliopi
  • Muñoz Labrador, Ana
  • Gabaldón, Matías
  • Moreno, F. Javier
  • Peron, Anne-Claire
  • Lemois, Maud
  • Landaud-Liautaud, Sophie
  • Rossi, Federica
  • Ferrocino, Ilario
  • Cocolin, Luca
[Data availability] The metataxonomic sequences are available at the European Nucleotide Archive (ENA) under the study accession numbers PRJEB113028., Taggiasca table olives are a native variety to Liguria (Italy) that undergo spontaneous fermentation in a traditional manner. The autochthonous microbiota of Taggiasca olives is typically dominated by yeasts, while lactic acid bacteria are often unable to compete probably due the high phenolic content of this variety. Consequently, the fermentation kinetics and metabolomic profile are determined primarily by indigenous yeasts., This study evaluated three autochthonous yeast starter cultures for Taggiasca fermentation under standard (10% w/v) and low (6% w/v) salt conditions. Three yeast strains (Pichia membranifaciens TUCC00000520, Candida diddensiae TUCC00000529, and Wickerhamomyces anomalus TUCC00000536), previously isolated from Taggiasca fermentations, were inoculated in different formulations. Dynamics of the microbial community were monitored with an integrated approach, using culture-dependent (plate counts, MALDI-TOF MS, and RAPD-PCR) and culture-independent methods (metataxonomics approach). The metabolome was characterized at the final stage of fermentation via organic acid determination, 1H NMR and untargeted volatile organic compounds (VOCs) analysis. Results highlighted an influence of the selected yeasts on the microbial dynamics and metabolomic profile of the final product with P. membranifaciens TUCC00000520 isolated until late stages of fermentation. Overall, this study validates the feasibility of autochthonous yeast-driven, cultivar-specific starters and provides a strategic framework for optimizing Taggiasca olive fermentation., This study was supported by the projects “Harnessing the microbial potential of fermented foods for healthy and sustainable food systems- DOMINO” that has received funding from the European Union‘s Horizon Europe research and innovation programme under grant agreement No. 101060218. The authors would like to acknowledge the Italian national Node MIRRI-IT of the European Research Infrastructure MIRRI-ERIC for supporting this study and Fratelli Merano S.p.A for kindly providing the samples used., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries

  • Piperni, Elisa
  • Vallès Colomer, Mireia
  • Asnicar, Francesco
Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p < 1e-16) and disorders linked to altered gut ecology (p < 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p < 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis., We thank the participants of the PREDICT program. This work was supported by Zoe Ltd. and TwinsUK, which are funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network, and the Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. It was partially supported by the American Gastroenterological Association Research Foundation’s Research Scholars Award to L.H.N., the Crohn’s and Colitis Foundation Career Development Award to L.H.N., and NIH/NIDDK K23DK125838 to L.H.N. L.H.N. is the Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine. The study was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European Union’s Horizon 2020 program (ONCOBIOME-825410 project, MASTER- 818368 project, and IHMCSA-964590) to N.S., by the European Union’s Horizon Europe program (DOMINO-101060218), by the European Union NextGenerationEU (INEST) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S. and R35 CA253178 to A.T.C., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Lifelines Biobank initiative has been made possible by the Dutch Ministry of Health, Welfare, and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen; the University of Groningen; and the Northern Provinces of the Netherlands. The authors acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants. J.F. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-CoG (No.101001678), NWO-VICI grant VI.C.202.022, the AMMODO Science Award 2023 for Biomedical Sciences from Stichting Ammodo, and the Netherlands Organ-on-Chip Initiative, an NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture, and Science of The Netherlands. A.Z. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-StG (No. 715772), NWO-VIDI grant 016.178.056, and the NWO Gravitation grant Exposome-NL (024.004.017). A.T.C. is partially supported by an American Cancer Society Research Professor Award.